Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 15 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (4)
P 1 (1)
P 4 (1)

Trial Status

Completed7
Recruiting6
Active Not Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT01145196RecruitingPrimary

Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

NCT03783351Not ApplicableActive Not Recruiting

Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)

NCT07085533Recruiting

Natural History Study of Inherited Retinal Diseases

NCT07138963Recruiting

Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies

NCT05623059Phase 1Completed

Evaluate Pharmacokinetics and Safety of Slow Release DHEA

NCT06892171Not ApplicableRecruiting

The Study of the Phenotype of Hereditary Xerocytosis

NCT06791421RecruitingPrimary

AI-Driven Genotype Prediction Using EHR and Multimodal Data

NCT05916287Not ApplicableRecruiting

FAMILY INHERITANCE, GENE-GENE AND GENE-ENVIRONMENT INTERACTIONS IN THE FIELD OF CARDIOVASCULAR AND RENAL DISEASES. Fifth Visit of the STANISLAS Cohort

NCT05449080CompletedPrimary

Disorders of Sex Development (DSD) 46.XY in Three Siblings

NCT01441141CompletedPrimary

Genetics and Pain Severity in Sickle Cell Disease

NCT00001284CompletedPrimary

Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers

NCT01088100CompletedPrimary

Study of the Correlation Between Specific Genes and Cognitive Dysfunction After Surgery

NCT01082796Not ApplicableCompletedPrimary

Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects

NCT00973037Unknown

CYP2D6 Genotype on the Clinical Effect of Tamoxifen

NCT00629967Phase 4Completed

A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

Showing all 15 trials

Research Network

Activity Timeline